Profound Medical Corp. - common stock (NQ:PROF)

6.020 -0.280 (-4.44%)

Streaming Delayed Price Updated: 2:16 PM EDT, Mar 27, 2026 Add to My Watchlist

Price and Volume

Volume	141,925
Open	6.190
Bid (Size)	5.940 (1,100)
Ask (Size)	6.100 (700)
Prev. Close	6.300
Today's Range	5.970 - 6.440
52wk Range	3.760 - 8.950
Shares Outstanding	20,208,948
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone

Today 7:45 EDT

From Profound Medical Corp.

Via GlobeNewswire

CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

March 13, 2026

From Profound Medical Corp.

Via GlobeNewswire

Performance

YTD	-21.4%	-21.4%
1 Month	-15.8%	-15.8%
3 Month	-18.3%	-18.3%
6 Month	+17.6%	+17.6%
1 Year	-7.4%	-7.4%

More News

Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24

March 09, 2026

From Profound Medical Corp.

Via GlobeNewswire

Earnings Scheduled For November 13, 2025 ↗

November 13, 2025

Via Benzinga

Here are the top movers in Friday's session. ↗

March 06, 2026

Via Chartmill

Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results

March 05, 2026

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow

February 12, 2026

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease

February 12, 2026

From Profound Medical Corp.

Via GlobeNewswire

PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health

February 05, 2026

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Announces Upcoming Investor Events

January 27, 2026

From Profound Medical Corp.

Via GlobeNewswire

Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO®

January 15, 2026

From Profound Medical Corp.

Via GlobeNewswire

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

January 06, 2026

From Profound Medical Corp.

Via GlobeNewswire

Profound Surpasses 2025 TULSA-PRO® Installed Base Goal

January 12, 2026

From Profound Medical Corp.

Via GlobeNewswire

InvestorNewsBreaks – Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) Closes $36 Million Registered Direct Offering

December 31, 2025

Via Investor Brand Network

Profound Medical Corp. Announces Closing of Private Placement

December 30, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Corp. Announces Upsize of Private Placement

December 24, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

December 23, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

December 19, 2025

From Profound Medical Corp.

Via GlobeNewswire

Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation

December 04, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Reports Strong Third Quarter 2025 Financial Results

November 13, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings

November 28, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand

November 12, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease

November 18, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia

November 11, 2025

From Profound Medical Corp.

Via GlobeNewswire

Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight

November 10, 2025

From Profound Medical Corp.

Via GlobeNewswire

Frequently Asked Questions

Is Profound Medical Corp. - common stock publicly traded?

Yes, Profound Medical Corp. - common stock is publicly traded.

What exchange does Profound Medical Corp. - common stock trade on?

Profound Medical Corp. - common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Profound Medical Corp. - common stock?

The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market

What is the current price of Profound Medical Corp. - common stock?

The current price of Profound Medical Corp. - common stock is 6.020

When was Profound Medical Corp. - common stock last traded?

The last trade of Profound Medical Corp. - common stock was at 03/27/26 02:16 PM ET

What is the market capitalization of Profound Medical Corp. - common stock?

The market capitalization of Profound Medical Corp. - common stock is 121.66M

How many shares of Profound Medical Corp. - common stock are outstanding?

Profound Medical Corp. - common stock has 122M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.